Triglycerides-diabetes association in healthy middle-aged men: Modified by physical fitness? A long term follow-up of 1962 Norwegian men in the Oslo Ischemia Study

Diabetes Research and Clinical Practice

Volumn 101, Issue 2, 2013, Pages 201-209

  Skretteberg, P T ^a,b   Grytten, A N ^b   Gjertsen, K ^b   Grundvold, I ^a,b   Kjeldsen, S E ^a,b   Erikssen, J ^b   Mellbin, L ^c   Liestol K ^d   Fraser, D A ^e   Erikssen, G ^f   Pedersen, T R ^a,b   Bodegard, J ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF OSLO   (Norway)

^e Pronova BioPharma Norge AS   (Norway)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Diabetes; Epidemiology; Fitness; Lipids; Prediction

Indexed keywords

GLUCOSE; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; ETHNIC GROUP; EXERCISE; EXERCISE TEST; FITNESS; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL DIABETES MELLITUS; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; NORWEGIAN; PREDICTION; RISK ASSESSMENT; RISK REDUCTION; SEDENTARY LIFESTYLE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84881245941     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.06.001     Document Type: Article

References (36)

1. Perry I.J., Wannamethee S.G., Walker M.K., Thomson A.G., Whincup P.H., Shaper A.G. Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. BMJ 1995, 310:560-564.
2. Tirosh A., Shai I., Bitzur R., Kochba I., Tekes-Manova D., Israeli E., et al. Changes in triglyceride levels over time and risk of type 2 diabetes in young men. Diabetes Care 2008, 31:2032-2037.
3. Dotevall A., Johansson S., Wilhelmsen L., Rosengren A. Increased levels of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women. A prospective 18-year follow-up of the BEDA study. Diabet Med 2004, 21:615-622.
4. Balkau B., Lange C., Fezeu L., Tichet J., de Lauzon-Guillain B., Czernichow S., et al. Predicting diabetes: clinical, biological, and genetic approaches: data from the epidemiological study on the insulin resistance syndrome (DESIR). Diabetes Care 2008, 31:2056-2061.
5. Lynch J., Helmrich S.P., Lakka T.A., Kaplan G.A., Cohen R.D., Salonen R., et al. Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent diabetes mellitus in middle-aged men. Arch Intern Med 1996, 156:1307-1314.
6. Katzmarzyk P.T., Craig C.L., Gauvin L. Adiposity, physical fitness and incident diabetes: the physical activity longitudinal study. Diabetologia 2007, 50:538-544.
7. Goodrich K.M., Crowley S.K., Lee D.C., Sui X.S., Hooker S.P., Blair S.N. Associations of cardiorespiratory fitness and parental history of diabetes with risk of type 2 diabetes. Diabetes Res Clin Pract 2012, 95:425-431.
8. Erikssen J., Skrede S. Serum lipids and latent coronary insufficiency. Scand J Clin Lab Invest 1977, 37:243-250.
9. Bodegard J., Skretteberg P.T., Gjesdal K., Pyorala K., Kjeldsen S.E., Liestol K., et al. Low-grade systolic murmurs in healthy middle-aged individuals: innocent or clinically significant? A 35-year follow-up study of 2014 Norwegian men. J Intern Med 2012, 271:581-588.
10. Skretteberg P.T., Grundvold I., Kjeldsen S.E., Erikssen J.E., Sandvik L., Liestol K., et al. HDL-cholesterol and prediction of coronary heart disease: modified by physical fitness? A 28-year follow-up of apparently healthy men. Atherosclerosis 2012, 220:250-256.
11. Mundal R., Erikssen J., Rodahl K. Assessment of physical activity by questionnaire and personal interview with particular reference to fitness and coronary mortality. Eur J Appl Physiol Occup Physiol 1987, 56:245-252.
12. Erikssen J., Enger S.C. Intravenous glucose tolerance test in middle-aged men with and without latent coronary heart disease. Acta Med Scand 1977, 202:357-362.
13. Hjelm M., De Verdierch C.H. A methodological study of the enzymatic determination of glucose in blood. Scand J Clin Lab Invest 1963, 15:415-428.
14. Sandvik L., Erikssen J., Thaulow E., Erikssen G., Mundal R., Rodahl K. Physical fitness as a predictor of mortality among healthy, middle-aged Norwegian men. N Engl J Med 1993, 328:533-537.
15. Zimmet P. Diabetes mellitus report of a WHO study group 1985, World Health Organization, Geneva.
16. Bjornholt J.V., Erikssen G., Liestol K., Jervell J., Thaulow E., Erikssen J. Type 2 diabetes and maternal family history: an impact beyond slow glucose removal rate and fasting hyperglycemia in low-risk individuals? Results from 22.5 years of follow-up of healthy nondiabetic men. Diabetes Care 2000, 23:1255-1259.
17. Shrier I., Platt R.W. Reducing bias through directed acyclic graphs. BMC Med Res Methodol 2008, 8:70.
18. Cowie C.C., Rust K.F., Byrd-Holt D.D., Eberhardt M.S., Flegal K.M., Engelgau M.M., et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 2006, 29:1263-1268.
19. Rathmann W., Haastert B., Icks A., Lowel H., Meisinger C., Holle R., et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia 2003, 46:182-189.
20. Whiting D.R., Guariguata L., Weil C., Shaw J. IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011, 94:311-321.
21. Langsted A., Freiberg J.J., Tybjaerg-Hansen A., Schnohr P., Jensen G.B., Nordestgaard B.G. Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up. J Intern Med 2011, 270:65-75.
22. Tirosh A., Shai I., Tekes-Manova D., Israeli E., Pereg D., Shochat T., et al. Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 2005, 353:1454-1462.
23. Erikssen G., Liestol K., Bjornholt J., Thaulow E., Sandvik L., Erikssen J. Changes in physical fitness and changes in mortality. Lancet 1998, 352:759-762.
24. Bonjer F.H. Measurement of working capacity by assessment of the aerobic capacity in a single session. Fed Proc 1966, 25:1363-1365.
25. Helmrich S.P., Ragland D.R., Leung R.W., Paffenbarger R.S. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 1991, 325:147-152.
26. Janiszewski P.M., Ross R. Physical activity in the treatment of obesity: beyond body weight reduction. Appl Physiol Nutr Metab 2007, 32:512-522.
27. Sieverdes J.C., Sui X., Lee D.C., Church T.S., McClain A., Hand G.A., et al. Physical activity, cardiorespiratory fitness and the incidence of type 2 diabetes in a prospective study of men. Br J Sports Med 2010, 44:238-244.
28. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997, 46:3-10.
29. Mostaza J.M., Vega G.L., Snell P., Grundy S.M. Abnormal metabolism of free fatty acids in hypertriglyceridaemic men: apparent insulin resistance of adipose tissue. J Intern Med 1998, 243:265-274.
30. Reaven G.M., Mejean L., Villaume C., Drouin P., Debry G. Plasma glucose and insulin responses to oral glucose in nonobese subjects and patients with endogenous hypertriglyceridemia. Metabolism 1983, 32:447-450.
31. Thiebaud D., DeFronzo R.A., Jacot E., Golay A., Acheson K., Maeder E., et al. Effect of long chain triglyceride infusion on glucose metabolism in man. Metabolism 1982, 31:1128-1136.
32. Lakka T.A., Salonen J.T. Physical activity and serum lipids: a cross-sectional population study in eastern Finnish men. Am J Epidemiol 1992, 136:806-818.
33. Julius U. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia. Exp Clin Endocrinol Diabetes 2003, 111:246-250.
34. Lim E.L., Hollingsworth K.G., Aribisala B.S., Chen M.J., Mathers J.C., Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 2011, 54:2506-2514.
35. Tirosh A., Rudich A., Shochat T., Tekes-Manova D., Israeli E., Henkin Y., et al. Changes in triglyceride levels and risk for coronary heart disease in young men. Ann Intern Med 2007, 147:377-385.
36. Surendran R.P., Visser M.E., Heemelaar S., Wang J., Peter J., Defesche J.C., et al. Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia. J Intern Med 2012, 272:185-196.